- £56.72m
- £52.42m
- £4.00m
REG - Creo Medical Group - Trading Update
AnnouncementRCS - Creo Medical Group - Strategic Collaboration with Khalifa University
AnnouncementRCS - Creo Medical Group - Speedboat® UltraSlim roll-out reaches Asia Pacific
AnnouncementREG - AIM - AIM Notice - 26/01/2024
AnnouncementREG - Creo Medical Group - Award of Shares under Share Incentive Plan
AnnouncementRCS - Creo Medical Group - First use of Speedboat® UltraSlim in Latin America
AnnouncementRCS - Creo Medical Group - First use of Speedboat® UltraSlim in the USA
AnnouncementRCS - Creo Medical Group - First European Speedboat® UltraSlim procedure
AnnouncementREG - Creo Medical Group - Capital Markets Day
AnnouncementREG - Creo Medical Group - Speedboat® UltraSlim: US FDA Clearance
AnnouncementREG - Creo Medical Group - SB UltraSlim: EU launch accelerated by 18 months
AnnouncementREG - Creo Medical Group - Change of Nominated Adviser and Joint Broker
AnnouncementRCS - Creo Medical Group - Investor Presentation
AnnouncementREG - Creo Medical Group - Half-year Report
AnnouncementREG - Creo Medical Group - Notice of Results
AnnouncementRCS - Creo Medical Group - Royal Oldham SSD service update
AnnouncementREG - Creo Medical Group - Half Year Trading Update
AnnouncementREG - Creo Medical Group - Total Voting Rights
AnnouncementREG - AIM - AIM Notice - 27/07/2023
Announcement